期刊文献+

宫颈神经内分泌癌21例临床分析 被引量:2

下载PDF
导出
摘要 目的:探讨宫颈神经内分泌癌(NECC)的临床病理特点和预后影响因素。方法:回顾分析2010年1月至2018年5月大连医科大学附属第一医院及大连医科大学附属大连市妇幼保健院收治的21例NECC患者的临床资料。结果:21例NECC患者临床分期:Ib1期13例,Ib2期4例,Ⅱa1期2例,Ⅱa2期1例,Ⅱb期1例。病理分型:小细胞癌11例,大细胞癌1例,非典型类癌2例,混合型7例。肿瘤形态:外生型18例,颈管型1例,溃疡型1例,1例肉眼未见病灶为活检发现。21例患者中经术后病理证实宫颈深间质浸润者12例(57.1%),淋巴血管间隙浸润(LVSI)者13例(61.9%),盆腔和(或)腹主动脉旁淋巴结转移者9例(42.9%)。随访时间7~103个月,21例患者中复发12例(57.1%),死亡9例(42.9%),3例带瘤生存。2年累积无进展生存率为56.1%,中位无进展生存时间为26个月,2年累积总生存率为73.4%,中位总生存时间为29个月。单因素分析显示,FIGO分期≥Ib2期、宫颈深间质浸润、淋巴结转移、肿瘤直径≥4cm是影响NECC预后的独立危险因素,术后辅助化疗可改善预后。多因素分析显示,肿瘤直径和淋巴结转移与预后有关。结论:NECC是宫颈癌的一种极少见病理类型,易发生宫颈深间质和淋巴脉管间隙浸润,淋巴结转移率高,预后差。FIGO分期、宫颈深间质浸润、淋巴结转移、肿瘤直径与预后相关,辅助化疗具有重要意义。
出处 《现代妇产科进展》 CSCD 北大核心 2019年第10期781-783,787,共4页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献2

二级参考文献20

  • 1[13]Kataoka TR,Tsukamoto Y,Matsumura M,et al.Expression of p21 Cip1/Waf1 and p27 Kip1 in small cell neuroendocrine carcinoma of the uterine cervix[J].Int J Surg Pathol,2008,16(1):11-15.
  • 2[14]Ohwada M,Wada T,Saga Y,et al.C-kit over expression in neuroendocrine small cell carcinoma of the uterine cervix[J].Eur J Gynaecol Oncol,2006,27(1):53-55.
  • 3[15]Tangjitgamol S,Ramirez PT,Sun CC,et al.Expression of HER-2/neu,epidermal growth factor receptor,vascular endothelial growth factor,cyclooxygenase-2,estrogen receptor,and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix:a clinicopathologic and prognostic study[J].Int J Gynecol Cancer,2005.15(4):646-656.
  • 4[16]Boruta DM 2nd,Schorge JO,Dusks LA,et al.Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix[J].Gynecol Oncol,2001,81(1):82-87.
  • 5[17]Viswanathan AN,Deavers MT,Jhingran A,et al.Small cell neuroendocrine carcinoma of the cervix:outcome and patterns of recurrence[J].Gynecol Oncol,2004,93(1):27-33.
  • 6[18]Morris M,Gershenson DM,Eifel P,et al.Treatment of small cell carcinoma of the cervix with cisplatin,doxorubicin,and etoposide[J].Gynecol Oncol,1992,47(1):62-65.
  • 7[19]Hoskins PJ,Swenerton KD,Pike JA,et al.Small-cell carcinoma of the cervix:fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinumbased combination chemotherapy[J].J Clin Oncol,2003,21(18):3495-3501.
  • 8[20]Clam JK,Loizzi V,Burger RA,et al.Prognostic factors in neuroendocrine small cell cervical carcinoma:a multivariate analysis[J].Cancer,2003,97(3):568-574.
  • 9[1]Albores-Saavedra J,Gersell D,Gilks CB,et al.Terminology of endocrine tumors of the uterine cervix:results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute[J].Arch Pathol Lab Med,1997,121(1):34-39.
  • 10[2]Tsunoda T,Jobo T,Arai M,et al.Small-cell carcinoma of the uterine cervix:a clinicopathologic study of 11 cases[J].Int J Gynecol Cancer,2005,15(2):295-300.

共引文献15

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部